Capital Research Global Investors’s Medtronic MDT Stock Holding History

Capital Research Global Investors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.63B	Buy	41,926,590 +7,353,427	+21%	+$704M	0.56%	40
2025 Q4	$3.32B	Buy	34,573,163 +3,880,174	+13%	+$377M	0.61%	34
2025 Q3	$2.92B	Sell	30,692,989 -5,666,473	-16%	-$521M	0.55%	41
2025 Q2	$3.17B	Sell	36,359,462 -5,208,154	-13%	-$442M	0.63%	34
2025 Q1	$3.74B	Buy	41,567,616 +8,363,931	+25%	+$748M	0.81%	34
2024 Q4	$2.65B	Buy	33,203,685 +571,700	+2%	+$49.5M	0.55%	44
2024 Q3	$2.94B	Buy	32,631,985 +899,967	+3%	+$75.7M	0.61%	43
2024 Q2	$2.5B	Buy	31,732,018 +847,606	+3%	+$69.5M	0.55%	44
2024 Q1	$2.69B	Buy	30,884,412 +2,044,109	+7%	+$174M	0.61%	42
2023 Q4	$2.38B	Sell	28,840,303 -3,288,638	-10%	-$251M	0.58%	42
2023 Q3	$2.52B	Buy	32,128,941 +635,170	+2%	+$53.2M	0.69%	36
2023 Q2	$2.77B	Buy	31,493,771 +1,475,241	+5%	+$127M	0.74%	34
2023 Q1	$2.42B	Buy	30,018,530 +1,203,861	+4%	+$98.1M	0.69%	36
2022 Q4	$2.24B	Buy	28,814,669 +37,199	+0.1%	+$3.01M	0.68%	43
2022 Q3	$2.32B	Buy	28,777,470 +2,742,283	+11%	+$246M	0.76%	34
2022 Q2	$2.34B	Buy	26,035,187 +4,011,590	+18%	+$406M	0.73%	30
2022 Q1	$2.44B	Buy	22,023,597 +1,405,249	+7%	+$148M	0.6%	42
2021 Q4	$2.13B	Buy	20,618,348 +1,974,556	+11%	+$229M	0.47%	49
2021 Q3	$2.34B	Buy	18,643,792 +105,057	+0.6%	+$13.6M	0.55%	41
2021 Q2	$2.3B	Buy	18,538,735 +3,337,462	+22%	+$419M	0.54%	40
2021 Q1	$1.8B	Buy	15,201,273 +5,419,122	+55%	+$635M	0.44%	50
2020 Q4	$1.15B	Buy	9,782,151 +2,559,030	+35%	+$282M	0.3%	85
2020 Q3	$751M	Buy	7,223,121 +91,576	+1%	+$9.2M	0.23%	103
2020 Q2	$654M	Buy	7,131,545 +377,038	+6%	+$36.2M	0.21%	108
2020 Q1	$609M	Buy	6,754,507 +673,266	+11%	+$71.6M	0.24%	92
2019 Q4	$690M	Buy	6,081,241 +743,510	+14%	+$81.6M	0.21%	110
2019 Q3	$580M	Buy	5,337,731 +978,189	+22%	+$102M	0.19%	118
2019 Q2	$425M	Sell	4,359,542 -2,092,842	-32%	-$191M	0.13%	146
2019 Q1	$588M	Sell	6,452,384 -220,784	-3%	-$19.8M	0.19%	112
2018 Q4	$607M	Buy	6,673,168 +577	+0%	+$53.9K	0.21%	98
2018 Q3	$656M	Sell	6,672,591 -6,739,153	-50%	-$623M	0.19%	114
2018 Q2	$1.15B	Sell	13,411,744 -3,447,949	-20%	-$288M	0.31%	75
2018 Q1	$1.35B	Sell	16,859,693 -8,501,104	-34%	-$701M	0.38%	63
2017 Q4	$2.05B	Sell	25,360,797 -3,990,443	-14%	-$320M	0.6%	46
2017 Q3	$2.28B	Sell	29,351,240 -2,107,156	-7%	-$175M	0.69%	38
2017 Q2	$2.79B	Sell	31,458,396 -2,187,417	-7%	-$184M	0.87%	30
2017 Q1	$2.71B	Sell	33,645,813 -3,658,983	-10%	-$286M	0.85%	27
2016 Q4	$2.66B	Sell	37,304,796 -663,218	-2%	-$52.1M	0.86%	32
2016 Q3	$3.28B	Buy	37,968,014 +462,891	+1%	+$40.3M	1.08%	22
2016 Q2	$3.25B	Buy	37,505,123 +358,123	+1%	+$29M	1.11%	20
2016 Q1	$2.79B	Sell	37,147,000 -338,000	-0.9%	-$25.5M	0.96%	26
2015 Q4	$2.88B	Buy	37,485,000 +7,578,000	+25%	+$570M	0.99%	28
2015 Q3	$2B	Sell	29,907,000 -2,253,000	-7%	-$166M	0.72%	35
2015 Q2	$2.38B	Buy	32,160,000 +4,470,000	+16%	+$342M	0.78%	32
2015 Q1	$2.16B	Buy	27,690,000 +13,391,000	+94%	+$1.01B	0.74%	33
2014 Q4	$1.03B	Buy	14,299,000 +3,263,000	+30%	+$227M	0.35%	77
2014 Q3	$684M	Buy	11,036,000 +5,762,351	+109%	+$366M	0.24%	106
2014 Q2	$336M	Buy	5,273,649 +4,823,649	+1,072%	+$293M	0.12%	172
2014 Q1	$27.7M	Hold	450,000	–	–	0.01%	364
2013 Q4	$25.8M	Hold	450,000	–	–	0.01%	368
2013 Q3	$24M	Sell	450,000 -5,100,000	-92%	-$274M	0.01%	388
2013 Q2	$286M	Buy	+5,550,000	New	+$274M	0.12%	167

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Capital Research Global Investors's MDT Position: Q1 2026 in Review

Capital Research Global Investors increased its Medtronic (MDT) stake by 21% in Q1 2026, buying an estimated $704M and bringing the position to 41,926,590 shares worth $3.63B. The position accounts for 0.56% of the portfolio, ranked #40.

Capital Research Global Investors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.74B in Q1 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Capital Research Global Investors held 41,926,590 shares of Medtronic worth $3.63B as of Q1 2026.
Capital Research Global Investors bought 7,353,427 Medtronic shares in Q1 2026, an estimated $704M.
Medtronic made up 0.56% of Capital Research Global Investors's portfolio in Q1 2026, its #40 holding.
Capital Research Global Investors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
Capital Research Global Investors's Medtronic position peaked at $3.74B in Q1 2025.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.